InvestorsHub Logo
Followers 25
Posts 2057
Boards Moderated 0
Alias Born 12/18/2012

Re: None

Monday, 03/13/2017 6:30:49 PM

Monday, March 13, 2017 6:30:49 PM

Post# of 17503
The phenominal data reported earlier from its mid-stage evaluation of its lupus drug, voclosporin, is allaying earlier fears about drug’s safety is beining to sink in. Because of this the offering is being seen as it should be, very positively, since profits from the drug will not need to be "partnered" with anyone else. We may see this surge tomorrow, and who knows, maybe some further guidance

Read more: Aurinia Offers Promising 2017 Forecast (AUPH) | Investopedia http://www.investopedia.com/news/aurinia-offers-promising-2017-forecast-auph/#ixzz4bFQijDEv
Follow us: Investopedia on Facebook
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News